SYDNEY, Oct. 1, 2025 /PRNewswire/ — SKINGRAPHICA is the first luxury skincare line for skin art, rewriting the rules of the multi billion-dollar tattoo industry. This Australian company has created a scientifically advanced, dermatologically tested, and performance-led skincare system specifically for tattooed skin.
The brand’s formulations are a world first, developed using a custom-built AI engine trained on skin science, biochemistry, and tattoo ink behavior, with human formulators finessing the final products. This innovative partnership has created a full line of products, including a world-first tattoo restoration cream called LUME.
Unlike most skincare, which is not designed for the altered structure and pigment of tattooed skin, SKINGRAPHICA uses targeted, stage-specific formulations. Tattoos live in the dermis, and general skincare often contains ingredients that are not Ink-Safe™. These include strong resurfacing acids, high-strength retinoids, and harsh peels, which can thin the skin, accelerate cell turnover, and blur or mute tattoo color. SKINGRAPHICA avoids these harsh, ink-compromising actives, engineering every formula with Ink-Safe™ biochemistry.
The brand’s core products address the full lifecycle of a tattoo:
Founded by Mat Baxter and artist Mikael Ramgard, SKINGRAPHICA bridges artistry and science to represent a new class of tattoo-dermatological adjuncts. With 6.6 million Australians having tattoos, and 39% of Gen Z having one, SKINGRAPHICA is meeting a clear customer need that has been ignored major beauty retailers. The brand is launching with a direct-to-consumer model, shipping to over 50 countries from October 1, 2025.
Media Contact:
Hollie Smith
hollie@shapr.com.au
Photo – https://mma.prnewswire.com/media/2784153/Founded_by_skin_artist_Mikael_Ramgard___Mat_Baxter.jpg
View original content:https://www.prnewswire.co.uk/news-releases/skingraphica-world-first-luxury-skincare-for-skinart-302571993.html
LISBON, Portugal, Nov. 11, 2025 /PRNewswire/ -- Crypto Content Creator Campus (CCCC), the global summit at…
TAMPA, Fla., Nov. 11, 2025 /PRNewswire/ -- Veterans Day – The Office of the Assistant…
Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1%…
Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™…
HANOVER, Germany, Nov. 11, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd.…
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global…